Third Line
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Folfiri as Third Line of Treatment (NCT03486379) | IRCCS Cancer Referral Center of Basilicata | 2016-03-01 |
Track Third Line automatically
Every clearance here is in the API, with alerts when new ones post.